LENZNASDAQLENZ Therapeutics Inc

LENZ price activity

Last Price

Change (24hr)

USD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

LENZ price performance

-8.51%

-10.53%

-67.06%

YTD

-82.71%

LENZ price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

US-NASDAQ rank

N/A

Sector Rank

N/A

LENZ details

View company website

View US-NASDAQ Official Page

LENZ Market Signals

More ways to discover

Browse United States news Discover NASDAQ signals Browse all NASDAQ stocks

LENZ Therapeutics Inc (US-NASDAQ: LENZ)

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Price: $5.27

Sector: Healthcare — Biotechnology